Amitriptyline for irritable bowel syndrome

Ordinarily used to treat other conditions, this trycylic antidepressant performed well in a recent trial on people with IBS. Irritable bowel syndrome (IBS) is estimated...

Study reveals risk of opioid dependence following surgery

A recent study from the University of South Australia has highlighted the significant number of patients at risk of developing opioid dependence post-surgery, calling...

World AIDS Day – 1 December

Men who have sex with men and use the human immunodeficiency virus (HIV) prevention pill have lower anxiety, new Australian research has revealed. Those who take...

PSA18 maps out the future of pharmacy

PSA18 has wrapped up in Sydney, with the future of pharmacy firmly in sight as PSA presented the Pharmacists in 2023 Discussion Paper, a...

Antioxidants and mineral supplements for slowing age-related macular degeneration

Age-related macular degeneration (AMD) is the most common cause of blindness in developed countries. The prevalence of AMD is 1.4% at 70 years of...

PSA successfully lobbies for pharmacist recommendations

Pharmacists have been recommended to access Medicare Benefits Schedule (MBS) items to manage medicines for patients who require complex care. The Pharmaceutical Society of Australia...